Stocks
Heron Therapeutics (HRTX) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -4.19 | -1.95 | -3.22 | -69.6 | -17.4 | -25.8 | ||
| Changes by years, y/y, % | -46% | -53% | +65% | +2 061% | -75% | +17.4% | |||
Heron Therapeutics. EV/EBITDA
Heron Therapeutics. EV/EBITDA, changes, %
Heron Therapeutics (HRTX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | -69.8 | 168.3 | 60.4 | -116.7 | -25.7 | -25.8 | |
| Changes by years, y/y, % | +1 942% | -2 516% | -472% | +449% | -63% | |||
| Changes by quarters, q/q, % | +228% | -341% | -64% | -293% | -78% | |||
